Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gregory Berk currently holds 278,058 shares of Hana Biosciences Inc (HNAB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gregory Berk has been a net neutral trader of HNAB stock. They have purchased $0 and sold $0 worth of shares.
Gregory Berk's most recent insider trade was on Feb 16, 2021, when they sold 278,058 shares at $0.00 per share.
Gregory Berk serves as Executive at Hana Biosciences Inc (HNAB). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Gregory Berk holds the position of Executive at Hana Biosciences Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Gregory Berk has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Gregory Berk was on Feb 16, 2021, when they purchased $0 worth of GTBP shares. This transaction involved 278,058 shares at N/A per share.
Gregory Berk currently owns 278,058 shares of Hana Biosciences Inc (HNAB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gregory Berk's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gregory Berk has 2 Form 4 filings on record as an insider at Hana Biosciences Inc.
Set alerts for Gregory Berk and 40,000+ other insiders.